X

Xenikos B.V.

14 employees

Xenikos is developing a combination of two toxin-loaded anti-T-cell antibodies.

Basic info

Industry

biotechnology research

Sectors

Medicine
Biotechnology
Clinical development
Immunotherapy
Therapeutics
Biopharmacy
Drug development
Life Science

Date founded

2009

Funding rounds raised

Total raised

$47M

from 7 investors over 7 rounds

X

Xenikos B.V. raised $47M on September 8, 2021

Investors: Veloxis Pharmaceuticals, Medicxi, RA Capital Management, L.P. and Oost NL

X

Xenikos B.V. raised $30M on May 15, 2018

Investors: Medicxi and RA Capital Management, L.P.

X

Xenikos B.V. raised $4.5M on June 19, 2012

Investors: Oost NL

FAQ